Polyclonal Antibody to Lamin A/C (LMNA) Homo sapiens (Human) Polyclonal antibody

CDCD1; CMD1A; CMT2B1; EMD2; FPL; FPLD; HGPS; IDC; LDP1; LFP; LGMD1B; LMN1; LMNC; PRO1; Cardiomyopathy Dilated 1A; Limb Girdle Muscular Dystrophy 1B; Progeria 1

Add to Cart Distributors
Overview
Properties
  • SourcePolyclonal antibody preparation, Host Rabbit
  • Ig Type IgG, Potency n/a
  • PurificationAntigen-specific affinity chromatography followed by Protein A affinity chromatography
  • LabelNone
  • Immunogen RPF550Hu01-Recombinant Lamin A/C (LMNA)
  • Buffer Formulation0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
  • TraitsLiquid, Concentration 0.34mg/ml
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Polyclonal Antibody to Lamin A/C (LMNA) Packages (Simulation)
  • Polyclonal Antibody to Lamin A/C (LMNA) Packages (Simulation)
  • Polyclonal Antibody to Lamin A/C (LMNA) IHC Images
  • PAF550Hu01.jpg Figure. Western Blot; Sample: Recombinant LMNA, Human.
  • Polyclonal Antibody to Lamin A/C (LMNA) Western Blot; Sample: Human A375 cell lysate;
    Primary Ab: 1µg/ml Rabbit Anti-Human LMNA Antibody
    Second Ab: 0.2µg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Specifity

The antibody is a rabbit polyclonal antibody raised against LMNA. It has been selected for its ability to recognize LMNA in immunohistochemical staining and western blotting.

Usage

Western blotting: 0.5-2µg/mL;1:170-680
Immunohistochemistry: 5-20µg/mL;1:17-68
Immunocytochemistry: 5-20µg/mL;1:17-68
Optimal working dilutions must be determined by end user.

Storage

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Stability

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Organism Species More: Mus musculus (Mouse), Rattus norvegicus (Rat)

Giveaways

Citations

  • Inactivation of the p53–KLF4–CEBPA Axis in Acute Myeloid LeukemiaPubMed: 26408402
  • Inactivation of the p53–KLF9–CEBPA Axis in Acute Myeloid LeukemiaPubMed: 26408402

Recommend products